Literature DB >> 18647248

Predicting the short form-6D preference-based index using the eight mean short form-36 health dimension scores: estimating preference-based health-related utilities when patient level data are not available.

Roberta Ara1, John Brazier.   

Abstract

OBJECTIVE: The objective is to derive an algorithm to predict a cohort preference-based short form-6D (short form-6D) score using the eight mean health dimension scores from the short form-36 (SF-36) when patient level data are not available.
METHODS: Health-related quality of life data (N = 6890) covering a wide range of health conditions was used to explore the relationship between the SF-6D and the eight health dimension scores. Models obtained using ordinary least square regressions were compared for goodness of fit and predictive abilities on both within-sample subgroups and out-of-sample published data sets.
RESULTS: The models explained more than 83% of the variance in the individual SF-6D scores with a mean absolute error of 0.040. When using mean health dimension scores from within-sample subgroups and out-of-sample published data sets, the majority of predicted scores were well within the minimal important difference (0.041) for the SF-6D.
CONCLUSIONS: This article presents a mechanism to estimate a mean cohort preference-based SF-6D score using the eight mean health dimension scores of the SF-36. Using published summary statistics, the out-of-sample validation demonstrates that the algorithms can be used to inform both clinical and economic research. Further research is required in different health conditions.

Entities:  

Mesh:

Year:  2008        PMID: 18647248     DOI: 10.1111/j.1524-4733.2008.00428.x

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  28 in total

1.  Economic evaluation of ropinirole prolonged release for treatment of Parkinson's disease in the Netherlands.

Authors:  Job F M van Boven; Annoesjka Novak; Maurice T Driessen; Cornelis Boersma; Maarten M Boomsma; Maarten J Postma
Journal:  Drugs Aging       Date:  2014-03       Impact factor: 3.923

Review 2.  Good practice guidelines for the use of statistical regression models in economic evaluations.

Authors:  Ben Kearns; Roberta Ara; Allan Wailoo; Andrea Manca; Monica Hernández Alava; Keith Abrams; Mike Campbell
Journal:  Pharmacoeconomics       Date:  2013-08       Impact factor: 4.981

3.  Low-dose SoluMatrix diclofenac in patients with osteoarthritis pain: impact on quality of life in a controlled trial.

Authors:  Vibeke Strand; Martin Bergman; Jasvinder A Singh; Allan Gibofsky; Alan Kivitz; Clarence Young
Journal:  Clin Rheumatol       Date:  2017-02-13       Impact factor: 2.980

4.  A preference-based measure of health: the VR-6D derived from the veterans RAND 12-Item Health Survey.

Authors:  Alfredo J Selim; William Rogers; Shirley X Qian; John Brazier; Lewis E Kazis
Journal:  Qual Life Res       Date:  2011-02-19       Impact factor: 4.147

5.  Predicting preference-based SF-6D index scores from the SF-8 health survey.

Authors:  P Wang; A Z Fu; H L Wee; J Lee; E S Tai; J Thumboo; N Luo
Journal:  Qual Life Res       Date:  2012-10-10       Impact factor: 4.147

Review 6.  The Use of Mapping to Estimate Health State Utility Values.

Authors:  Roberta Ara; Donna Rowen; Clara Mukuria
Journal:  Pharmacoeconomics       Date:  2017-12       Impact factor: 4.981

7.  Using Electronic Health Records to Enhance a Peer Health Navigator Intervention: A Randomized Pilot Test for Individuals with Serious Mental Illness and Housing Instability.

Authors:  Erin L Kelly; Joel T Braslow; John S Brekke
Journal:  Community Ment Health J       Date:  2018-05-03

Review 8.  A review of quality of life instruments used in liver transplantation.

Authors:  Colleen L Jay; Zeeshan Butt; Daniela P Ladner; Anton I Skaro; Michael M Abecassis
Journal:  J Hepatol       Date:  2009-07-28       Impact factor: 25.083

9.  Predicting an SF-6D preference-based score using MCS and PCS scores from the SF-12 or SF-36.

Authors:  Janel Hanmer
Journal:  Value Health       Date:  2009-03-24       Impact factor: 5.725

10.  Cost-utility analysis of radical nephrectomy versus partial nephrectomy in the management of small renal masses: Adjusting for the burden of ensuing chronic kidney disease.

Authors:  Zachary Klinghoffer; Jean-Eric Tarride; Giacomo Novara; Vincenzo Ficarra; Anil Kapoor; Bobby Shayegan; Luis H Braga
Journal:  Can Urol Assoc J       Date:  2013 Mar-Apr       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.